Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
fosfomycintromethamin 3 g brev |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fosfomycin tromethamine |
Inferred relationship |
Some |
|
Fosfomycin tromethamine 3g granule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fosfomycin tromethamine |
Inferred relationship |
Some |
|
fosfomycintromethamin 3 g brev |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fosfomycin tromethamine |
Inferred relationship |
Some |
|
Product containing precisely fosfomycin (as fosfomycin tromethamine) 3 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Fosfomycin tromethamine |
Inferred relationship |
Some |
1 |
Fosfomycin (as fosfomycin tromethamine) 3 g granules for oral solution sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fosfomycin tromethamine |
Inferred relationship |
Some |
1 |